United States· US:55154-9554_858b3d0d-fbaf-47dc-ab92-3afe2877fdd1
Hydralazine Hydrochloride
A hydralazine product containing hydralazine hydrochloride, registered in United States by Cardinal Health 107, LLC. The same ATC class is registered in 6 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Hydralazine is registered in 6 of 19 countries.
Countries holding a registration under ATC C02DB02 (hydralazine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Hydralazine · ATC C02DB02
6 / 19 countries
- Canada
- Finlandprice
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HYDRALAZINE HYDROCHLORIDE
- Manufacturer
- Cardinal Health 107, LLC
- Country
- United States (US)
- ATC code
- C02DB02
- ATC class
- Hydralazine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc1155154955455 VIAL, SINGLE-DOSE in 1 BAG (55154-9554-5) / 1 mL in 1 VIAL, SINGLE-DOSE
Regulatory notes
Interactions
163 interactions on record for hydralazine.
Graded by severity as the source publishes them — 145 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydralazine · interactions on record
163 records
- 145 moderate
- 1 minor
- 17 info
Most severe, free to view
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hydralazine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomApo-Hydralazine 10mg tabletsImported (United States)
- CanadaAPO-HYDRALAZINEAPOTEX INC
- SpainHYDRAPRES 20 mg POLVO PARA SOLUCIÓN INYECTABLELaboratorios Rubio S.A.
- NorwayApresolinAmdipharm Limited
- SwedenApresolin 25 mg TablettAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Cyprus · Hydralazine Remedica
- Spain · Hydrapres
- United Kingdom (Northern Ireland) · Apresoline, Hydralazine Accord-Uk
- Malta · Hydralazine Remedica
- Norway · Apresolin
- Sweden · Apresolin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b284ff25-b89b-4cbf-88d4-033fe2a835d8 GET /v1/drugs/b284ff25-b89b-4cbf-88d4-033fe2a835d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "FD171B778Y",
"rxcui": "82027",
"inchikey": "ZUXNZUWOTSUBMN-UHFFFAOYSA-N",
"display_name": "HYDRALAZINE HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAMUSCULAR; INTRAVENOUS",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 1
},
"spl_meta": {
"a1066707-2391-4918-8ded-600c017fde48": {
"match": "brand_token",
"title": "HYDRALAZINE HYDROCHLORIDE TABLET [CARDINAL HEALTH 107, LLC]",
"spl_version": "4",
"published_date": "2026-06-01"
}
},
"productid": "55154-9554_858b3d0d-fbaf-47dc-ab92-3afe2877fdd1",
"productndc": "55154-9554",
"dosage_form": "INJECTION",
"orange_book": {
"appl_no": "040388",
"products": [
{
"rs": true,
"rld": false,
"te_code": "AP",
"strength": "20MG/ML",
"product_no": "001",
"approval_date": "Mar 13, 2001"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "HYDRALAZINE HYDROCHLORIDE",
"proprietary_name": "Hydralazine Hydrochloride",
"active_ingred_unit": "mg/mL",
"application_number": "ANDA040388",
"marketing_category": "ANDA",
"nonproprietary_name": "HYDRALAZINE HYDROCHLORIDE",
"start_marketing_date": "20010905",
"active_numerator_strength": "20"
}See everything about hydralazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.